Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
533.36
-19.79 (-3.58%)
Nov 3, 2026, 3:11 PM EST - Market open

Vertex Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Net Income
1,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1
Depreciation & Amortization
56.555.924.55451.748.421.353.25453.547.242.141.438.838.436.737.335.933.8
Other Amortization
--31.2---25.2---11.8--------
Asset Writedown & Restructuring Costs
-----379-------------
Loss (Gain) From Sale of Investments
---12.22.6---50.510.812.7270.46.20.4-6.46-16.784.275.6-12.1
Stock-Based Compensation
170.2166.4157.6194.9167.3166.1167.8184.6154.2191.9208.6130.9119.3122.4111.5135.6113.9130.3118.6
Other Operating Activities
-86.1-70.353.6-242.6-46.4-152.468-81.7-139.5-194.7-163.3-135-187.8-93.6194.5-211.4-289.8-14.9-50
Change in Accounts Receivable
-140.239.8-99.4-59.9-18.4-169.669-51.8135.1-251.615.4-6.1-2.9-90.510.2-119.5-84.1-165.2-43.5
Change in Inventory
-27.7-97.7-77.4-131.1-148.6-167.1-147.5-182.5-107.2-80.1-70-97.5-72.8-82.6-78.3-26.8-33.32-27
Change in Accounts Payable
-66.735.638.3-35.37.626.28.466.1-25.10.1-31.89.235.635.7159.9-69.945.3-14.553.9
Change in Other Net Operating Assets
119.6267-809.3375.92742-490.1325.7-244.2460.9-752.5283.3285.5276.3-182.7297455.8144.9151.2
Operating Cash Flow
1,1251,4284981,2411,073818.9584.61,370-3,7541,307234.61,2681,134899.91,078955.51,140956.2995
Operating Cash Flow Growth (YoY)
4.87%74.39%-14.81%-9.37%--37.33%149.19%7.99%-45.19%-78.25%32.75%-0.47%-5.89%8.38%3.05%-3.82%102.43%

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Capital Expenditures
-112.2-133.4-149.4-101.8-145.7-40.7-92.6-67.7-69-68.4-58.1-40.6-59.6-42.1-33.6-54.2-53.3-63.6-61.8
Cash Acquisitions
----------------295.9---
Sale (Purchase) of Intangibles
---------7.7-180-58--------
Investment in Securities
-7.4-298.5-122.8-16-334.5-9.8-698.4-272.2-372-1,888-770.4-76-214.4-1,792209.2-34.1-8.212.6-72.2
Other Investing Activities
73.8--15.90.8-4.3-5.3-30.9-8.1-15---1.1-29.9------
Investing Cash Flow
-45.8-431.9-288.1-117-484.5-55.8-821.9-348-463.7-2,136-886.5-117.7-303.9-1,834175.6-384.2-61.5-51-134

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Total Debt Issued
--------------3.5---10
Long-Term Debt Repaid
----------13.2----10.6----12.9-
Total Debt Repaid
---1.4-1.4---1.3-5.4-13.7-13.2-12-11.3-11-10.6-10.4-49.5-12.7-12.9-12.4
Net Debt Issued (Repaid)
---1.4-1.4---1.3-5.4-13.7-13.2-12-11.3-11-10.6-6.9-49.5-12.7-12.9-2.4
Issuance of Common Stock
47.727547.949.116.734.38.45516.946.415.458.614.251.636.664.433.734.7
Repurchase of Common Stock
-473.8-565.4-130.9-1,162-397.7-696.6-425.2-391.4-400.8-364.7-152.7-170.2-31.4-299.4-2.1-48-4.4-117.5-369.9
Other Financing Activities
-0.6-0.41.11.1-0.6-0.50.90.90.93.5-1.51.11.11.1-2.40.70.41.31.4
Financing Cash Flow
-426.7-538.8-77.2-1,155-349.2-680.4-391.3-387.5-358.6-357.5-119.8-16517.3-294.740.2-60.247.7-95.4-336.2

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Foreign Exchange Rate Adjustments
-3.7-40.37.3-4.157.230.5-47.322.8-2.5-15.627.4-22.5101240.8-38.2-25.9-5.9-4.9
Net Cash Flow
649.2417.1140-34.2296.6113.2-675.9657.1-4,578-1,203-744.3963.2857.8-1,2161,335472.91,100803.9519.9

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
1,0131,295348.61,140927.4778.24921,302-3,8231,238176.51,2281,075857.81,045901.31,087892.6933.2
Free Cash Flow Growth (YoY)
9.25%66.37%-29.15%-12.48%--37.15%178.75%6.05%-44.35%-83.11%36.23%-1.08%-3.90%11.96%3.03%-5.00%110.26%
Free Cash Flow Margin
30.39%43.35%10.93%37.04%31.28%28.09%16.90%46.98%-144.49%46.02%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.55%45.03%
Free Cash Flow Per Share
3.975.051.364.423.583.001.894.99-14.814.740.684.714.133.294.013.474.203.463.63
Levered Free Cash Flow
757.041,012-155.81,019912.38802.04184.641,094629.83891.33448.38923.761,0451,093857.64633.131,045771.31711.03
Unlevered Free Cash Flow
757.041,012-153.741,021912.38802.04186.391,099636.01897.83455930.581,0521,100864.89641.691,055780.63720.47

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash Interest Paid
3.13.233.23.52.72.78.19.71010.510.610.911.111.21413.413.713.6
Cash Income Tax Paid
419.282.3389.4479.6513.3184.4271.8278.549734.8758.2300.4498.4120.3217.7361.8393.38594.8
Change in Working Capital
-115244.7-947.8149.6-132.4-268.5-560.2157.5-241.4129.3-838.9188.9245.4138.9-90.980.8383.7-32.8134.6
SEC Filings: 10-K · 10-Q